Dra. MarΓ­a Natalia Gandur Quiroga (@nataliagandur) 's Twitter Profile
Dra. MarΓ­a Natalia Gandur Quiroga

@nataliagandur

Leader GU @InstitutoRoffo #GU #RCC #prostate #bladder #testis #GUcsm #clinicaltrials #Immunotherapy #PrecisionMedicine #OncoAlert #OncoReporte
Views Mine

ID: 1001912023750529024

calendar_today30-05-2018 19:43:35

6,6K Tweet

2,2K Followers

1,1K Following

Dra. MarΓ­a Natalia Gandur Quiroga (@nataliagandur) 's Twitter Profile Photo

πŸŒŸπŸŽ“πŸ‘πŸ§΅ RCC Highlights @ #ASCO25 | Part 1 πŸ’¬ Brilliant discussion by Tian Zhang, MD, MHS on 4 pivotal studies in advanced ccRCC OncoAlert πŸ”Ή #Abstract4505 | CheckMate 214 – NIVO+IPI vs SUN (Marc Motzer et al) βœ”οΈ 9-year follow-up βœ”οΈ OS benefit in all IMDC groups βœ”οΈ 108-mo OS: 31% vs 20%

πŸŒŸπŸŽ“πŸ‘πŸ§΅ RCC Highlights @ #ASCO25 | Part 1
πŸ’¬ Brilliant discussion by <a href="/TiansterZhang/">Tian Zhang, MD, MHS</a> on 4 pivotal studies in advanced ccRCC
<a href="/OncoAlert/">OncoAlert</a>
πŸ”Ή #Abstract4505 | CheckMate 214 – NIVO+IPI vs SUN (<a href="/motzer/">Marc Motzer</a> et al)
βœ”οΈ 9-year follow-up
βœ”οΈ OS benefit in all IMDC groups
βœ”οΈ 108-mo OS: 31% vs 20%